Elicio Therapeutics, Inc. (ELTX)

CIK 1601485 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Elicio Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 202640001979324-26-000002
Sep 2, 202640001230486-26-000002
Sep 2, 202640001413350-26-000009
Sep 2, 202640001441889-26-000002
Sep 2, 202640001761748-26-000002
Sep 2, 202640001187308-26-000004
Sep 2, 202640001267490-26-000010
Aug 13, 202610-Q0001601485-26-000056
Aug 13, 20268-K0001601485-26-000055
Jul 17, 202640001979163-26-000002
Jul 17, 202640001796436-26-000002
Jul 17, 202640001787403-26-000002
Jul 17, 202640001612095-26-000002
Jul 16, 2026SCHEDULE 13G0002145902-26-000001
Jul 8, 2026SCHEDULE 13G/A0001104659-26-081751
Jul 2, 20268-K0001104659-26-080058
Jul 2, 2026424B50001104659-26-080106
Jun 24, 20268-K0001601485-26-000050
Jun 17, 20268-K0001601485-26-000048
Jun 15, 20268-K0001601485-26-000046
May 11, 20268-K0001601485-26-000041
May 11, 202610-Q0001601485-26-000042
Apr 29, 202610-K/A0001601485-26-000035
Mar 16, 2026EFFECT9999999995-26-000830
Mar 16, 2026424B50001628280-26-017941